Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

Losartan decreases vessel size but not effect microvessel density or pericyte recruitment in Pan02 tumors grown in <i>SPARC−/−</i> animals. by Shanna A. Arnold (183991)

Follistatin expression is decreased and the MAPK signaling pathway is activated in <i>Med1^epi−/−</i> mice keratinocytes <i>in vitro</i>. by Fumihito Noguchi (615295)

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

Effect of L-NMMA and glucagon on insulin sensitivity. by Rita S. Patarrão (737406)

IFNγ and CXCL10 has a key role in CD20-TCB T cell recruitment. by Floriana Cremasco (5580266)

“…Shown are individual track values as scattered dots, and means +/- s.d. Kruskal-Wallis test. ****p<0.0001. d) IFNγ and (e) CXCL10 protein quantification by multiplex analysis of supernant derived from co-culture of WSU DLCL2 cells with decreasing amounts of T cells stimulated with 200 ng/ml of CD20-TCB for 16 hours. …”

Supplementary Material for: Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a... by figshare admin karger (2628495)

“…At randomization, iPTH had to be 300-<1,200 pg/mL, 25D <50 ng/mL, corrected serum calcium <9.8 mg/dL and phosphorus <6.5 mg/dL. …”

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution by Oliver Grottke (584154)

CD20-TCB induces resident T cell proliferation and recruitment of peripheral blood T cells. by Floriana Cremasco (5580266)

“…Pre-activated CD8 T cells have been plated with WSU DLCL2 cells at decreasing T cells: Tumor cells ratios, in the presence of 200 ng/ml of CD20-TCB. 24h later the supernatant has been collected and transferred to the bottom chamber of a 24-Transwell plate. …”

Additional file 2 of Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes by Xing Ji (3096735)

“…Osteoblasts were treated with vehicle or varying concentrations of FGL2 (50, 200 ng/mL) under normal (vehicle) and high glucose (4.5 mg/mL) conditions, and relative cell proliferation was assessed after 48 h to compare the effects under these different conditions. …”